In September 2019, the U.S. Food and Drug Administration (FDA) and drug-safety officials from the equivalent European agency issued a warning about Zantac and other ranitidine-based medications containing dangerous levels of N-nitrosodimethylamine (NDMA).

This chemical is a dangerous and volatile substance that the U.S. Environmental Protection Agency (EPA) and the World Health Organization (WHO) classified as part of “a family of potent carcinogens” known as N-nitrosamines.

Learn More: Zantac Lawsuit


Support the Show.